Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination drug consisting of **sodium fluoride**, a widely used anticaries agent, and **hops extract** derived from Humulus lupulus. Sodium fluoride facilitates the remineralization of tooth enamel by incorporating fluoride ions into the hydroxyapatite structure to form fluorapatite, making enamel more resistant to acid demineralization and bacterial action. Hops extract contains a variety of bioactive phytochemicals, including prenylated flavonoids (such as xanthohumol, 8-prenylnaringenin), alpha acids (such as humulone), and beta acids (such as lupulone), which demonstrate antibacterial, anti-inflammatory, and potential anticaries properties. Hops extract has also been investigated for its ability to inhibit oral bacteria and reduce caries, white spots, gingivitis, and inflammation in oral tissues. The combination may be formulated in oral care products such as toothpaste or mouthwash, primarily aimed at preventing dental caries, gingivitis, and oral biofilm-associated diseases[2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium fluoride + hops extract.